It is estimated that dermatologists are only treating 5% of people with the risk profile for skin cancers and as one of the five cancers seeing rapid growth SkinVision’s application can make healthcare information more accessible to consumers.
Today the application focuses on lesions, taking pictures of moles using a standard smartphone camera and assessing images against its proprietary algorithm to ensure over 80% accuracy in the identification process. A key element of LEO Pharma’s investment will be enabling SkinVision to develop uses of the technology in other skin disease areas, because its database of over 1M+ images has already begun to store examples of a wide range of skin conditions.
“We are delighted to reach this agreement with LEO Pharma, because it will enable us to expand into new areas and it validates our approach,” said Dick Uyttewaal, CEO of SkinVision B.V. “LEO Pharma has a great reputation and range of products in the treatment of skin conditions, so there is clear synergy between the two companies. We want to be the leading provider of digital solutions for skin conditions and together with LEO Pharma we believe we can provide consumers with even more personalized, informative healthcare services.”
The application works by consumers taking pictures of moles, which are then analysed using an algorithm to identify potential abnormal growth. The app evaluates the risk level with an online assessment based on a traffic light of red, orange or green. Characteristics of unnatural growth could indicate a developing melanoma (code red), or if further research is needed (code orange). In both cases, the patient is referred to a dermatologist. Users can archive their skin lesions to track for changes over time or can share the images with their doctor through the app when they feel uncomfortable. The application is the only skin cancer detection app that has received European CE certification, following its scientific testing by the university clinic of Ludwig Maximillian University (LMU) in Munich in 2013. This clinic is recognised as one of Europe’s premier academic and research institutions specialising in skin cancer.
For more information visit SkinVision.